CONGRESS COVERAGE: EHA 2020 – FOCUS ON LEUKEMIA AND MDS

Clinical trials updates, emerging therapies, and future directions in acute lymphoblastic leukemia (ALL), myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML)

Faculty Co-Chair

Dieter Hoelzer, MD, PhD Aptitude Health EPICS Leukemia

Dieter Hoelzer, MD, PhD

University of Frankfurt, Frankfurt, Germany

Faculty Co-Chair

Elias Jabbour, MD

University of Texas MD Anderson Cancer Center, Houston, TX, USA

LOOK INSIDE THIS REPORT

Download a sample of the meeting report and start discovering the insights:

Report Topics Include

  • MDS
  • Elderly/Unfit AML Patients
  • IDH– and FLT3-Mutant AML Patients
  • Emerging Immune Therapies in AML
  • Updates in ALL
  • Strategic Insights and Key Takeaways

Co-Chairs

Dieter Hoelzer, MD, PhD
University of Frankfurt, Frankfurt, Germany

Elias Jabbour, MD
University of Texas MD Anderson Cancer Center, Houston, TX, US

 

Faculty Members

Daniel DeAngelo, MD, PhD
Dana-Farber Cancer Institute, Boston, MA, US

Naval Daver, MD
University of Texas MD Anderson Cancer Center, Houston, TX, US

Gert Ossenkoppele, MD, PhD
VU Medical Center, Amsterdam, The Netherlands

Josep-Maria Ribera, MD, PhD
Hospital Universitari Germans Trias i Pujol, Barcelona, Spain

Valeria Santini, MD
University of Florence, Florence, Italy

Jorge Sierra, MD, PhD
Hospital de la Santa Creu I Sant Pau, Barcelona, Spain

Explore Available and Upcoming Insight Reports

View Reports